The angiogenesis promoter, proadrenomedullin nterminal 20 peptide (PAMP), improves healing in both normoxic and ischemic wounds either alone or in combination with autologous stem/progenitor cells

Histology and Histopathology

Volumn 28, Issue 1, 2013, Pages 115-125

  García Honduvilla, Natalio ^a   Cifuentes, Alberto ^a   Bellón, Juan Manuel ^a   Buján, Julia ^a   Martínez, Alfredo ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

Author keywords

Ischemic wounds; PAMP; Rabbit ear model; Stem progenitor cells; Wound healing

Indexed keywords

ADRENOMEDULLIN; ANGIOGENIC FACTOR;

ANIMAL; ARTICLE; AUTOTRANSPLANTATION; DRUG EFFECT; ISCHEMIA; MALE; NEW ZEALAND; PHYSIOLOGY; RABBIT; STEM CELL TRANSPLANTATION; WOUND HEALING;

ADRENOMEDULLIN; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ISCHEMIA; MALE; NEW ZEALAND; RABBITS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; WOUND HEALING;

ORYCTOLAGUS CUNICULUS;

EID: 84872196493     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bao P., Kodra A., Tomic-Canic M., Golinko M.S., Ehrlich H.P. and Brem H. (2009). The role of vascular endothelial growth factor in wound healing. J. Surg. Res. 153, 347-358.
2. Biressi S. and Rando T.A. (2010). Heterogeneity in the muscle satellite cell population. Semin. Cell. Dev. Biol. 21, 845-854.
3. Bujan J., Pascual G., Corrales C., Gomez-Gil V., Garcia-Honduvilla N. and Bellon J.M. (2006). Muscle-derived stem cells used to treat skin defects prevent wound contraction and expedite reepithelialization. Wound Repair Regen. 14, 216-223.
4. Bujan J., Pascual G., Corrales C., Gomez-Gil V., Rodriguez M. and Bellon J.M. (2005). Muscle-derived stem cells in tissue engineering: defining cell properties suitable for construct design. Histol. Histopathol. 20, 891-899.
5. Chien S. (2007). Ischemic rabbit ear model created by minimally invasive surgery. Wound Repair Regen. 15, 928-935.
6. De Haro J., Acin F., Lopez-Quintana A., Florez A., Martinez-Aguilar E. and Varela C. (2009). Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease. Heart Vessels 24, 321-328.
7. Diehm N., Silvestro A., Baumgartner I., Do D.D., Diehm C., Schmidli J. and Dick F. (2009). Chronic critical limb ischemia: European experiences. J. Cardiovasc. Surg. 50, 647-653.
8. Garayoa M., Martinez A., Lee S., Pio R., An W.G., Neckers L., Trepel J., Montuenga L.M., Ryan H., Johnson R., Gassmann M. and Cuttitta F. (2000). Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol. 14, 848-862.
9. Gloviczki P. and Yao J. (2001). Handbook of venous disorders: guidelines of the American Venous Forum, 2nd edn. London.
10. Guo S. and DiPietro L.A. (2010). Factors affecting wound healing. J. Dent. Res. 89, 219-229.
11. Habacher W., Rakovac I., Gorzer E., Haas W., Gfrerer R.J., Wach P. and Pieber T.R. (2007). A model to analyse costs and benefit of intensified diabetic foot care in Austria. J. Eval. Clin. Pract. 13, 906-912.
12. Hong S.J., Traktuev D.O. and March K.L. (2010). Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr. Opin. Organ. Transplant. 15, 86-91.
13. Kim I.Y., Seo S.J., Moon H.S., Yoo M.K., Park I.Y., Kim B.C. and Cho C.S. (2008). Chitosan and its derivatives for tissue engineering applications. Biotechnol. Adv. 26, 1-21.
14. Lejay A., Georg Y., Bajcz C., Thaveau F., Geny B., Kretz J.G. and Chakfe N. (2009). Endovascular treatment of infra-popliteal arteries in patients with critical limb ischemia. Acta Chir. Belg. 109, 684-693.
15. Liu J., Bian Z., Kuijpers-Jagtman A.M. and Von den Hoff J.W. (2010). Skin and oral mucosa equivalents: construction and performance. Orthod. Craniofac. Res. 13, 11-20.
16. Lopez J. and Martinez A. (2002). Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int. Rev. Cytol. 221, 1-92.
17. Macri L. and Clark R.A. (2009). Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol. Physiol. 22, 83-93.
18. Martinez A., Bengoechea J.A. and Cuttitta F. (2006). Molecular evolution of proadrenomedullin N-terminal 20 peptide (PAMP): evidence for gene co-option. Endocrinology 147, 3457-3461.
19. Martinez A., Elsasser T.H., Muro-Cacho C., Moody T.W., Miller M.J., Macri C.J. and Cuttitta F. (1997). Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology 138, 5597-5604.
20. Martinez A., Sidhu G., Maheshwari R. and Cuttitta F. (1999). Adrenomedullin involvement in wound repair. 81st Annual Meeting of the Endocrine Society.
21. Martinez A., Zudaire E., Portal-Nunez S., Guedez L., Libutti S.K., Stetler-Stevenson W.G. and Cuttitta F. (2004). Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res. 64, 6489-6494.
22. Moore R.A., Liedl D.A., Jenkins S. and Andrews K.L. (2008). Using a silver-coated polymeric substrate for the management of chronic ulcerations: the initial Mayo Clinic experience. Adv. Skin Wound Care 21, 517-520.
23. Moreira M.E., Markovchick V.J. (2007). Wound management. Emerg. Med. Clin. North Am. 25, 873-899.
24. Newman M.I., Baratta L.G. and Swartz K. (2008). Activated, type I collagen (CellerateRx) and its effectiveness in healing recalcitrant diabetic wounds: a case presentation. Adv. Skin Wound Care 21, 370-374.
25. Rozman P. and Bolta Z. (2007). Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol. Alp. Panonica Adriat. 16, 156-165.
26. Scuderi N., Anniboletti T., Carlesimo B. and Onesti M.G. (2009). Clinical application of autologous three-cellular cultured skin substitutes based on esterified hyaluronic acid scaffold: our experience. In Vivo 23, 991-1003.
27. Sood R., Balledux J., Koumanis D.J., Mir H.S., Chaudhari S., Roggy D., Zieger M., Cohen A. and Coleman J.J. (2009). Coverage of large pediatric wounds with cultured epithelial autografts in congenital nevi and burns: results and technique. J. Burn Care Res. 30, 576-586.
28. Sorrell J.M. and Caplan A.I. (2010). Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res. Ther. 1, 30
29. Takahashi P.Y., Kiemele L.J., Chandra A., Cha S.S. and Targonski P.V. (2009). A retrospective cohort study of factors that affect healing in long-term care residents with chronic wounds. Ostomy Wound Manage 55, 32-37.
30. Ulicna M., Danisovic L. and Vojtassak J. (2010). Does cell therapy and tissue engineering represent a promising treatment of diabetic foot ulcers? Bratisl. Lek. Listy. 111, 138-143.
31. Vergano-Vera E., Fernandez A.P., Hurtado-Chong A., Vicario-Abejon C. and Martinez A. (2010). Lack of adrenomedullin affects growth and differentiation of adult neural stem/progenitor cells. Cell Tissue Res. 340, 1-11.
32. Welsch U., Unterberger P., Hofter E., Cuttitta F and Martinez A. (2002). Adrenomedullin in mammalian and human skin glands including the mammary gland. Acta Histochem. 104, 65-72.
33. Wu X., Wang S., Chen B. and An X. (2010). Muscle-derived stem cells: isolation, characterization, differentiation, and application in cell and gene therapy. Cell Tissue Res. 340, 549-567.
34. Yagmur C., Akaishi S., Ogawa R. and Guneren E. (2010). Mechanical receptor-related mechanisms in scar management: a review and hypothesis. Plast. Reconstr. Surg. 126, 426-434.
35. Zaulyanov L. and Kirsner R.S. (2007). A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Clin. Interv. Aging 2, 93-98.